Y. Ding and W. Liu, “Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons”, Acta Derm Venereol, vol. 106, pp. adv–2025, Apr. 2026.